An employee at German biopharmaceutical company CureVac demonstrates research workflow on a vaccine for Covid-19 a laboratory in Tuebingen, Germany, on Thursday. Photo: Reuters

Coronavirus: ‘Germany not for sale,’ says minister after ‘US tried to buy vaccine rights’

  • US allegedly offered local firm CureVac US$1 billion for exclusive rights to vaccine, according to German newspaper
  • Company denies receiving offer from US government and declines to give details about surprise change in CEO
Topic |   Coronavirus outbreak
An employee at German biopharmaceutical company CureVac demonstrates research workflow on a vaccine for Covid-19 a laboratory in Tuebingen, Germany, on Thursday. Photo: Reuters
READ FULL ARTICLE